News & Updates

Magazine article

Harnessing artificial intelligence to identify new drug combinations

Artificial intelligence (AI) has helped scientists propose a promising new drug combination for DIPG brain tumours. Prof Chris Jones, Director of the Brain Tumour Research Centre of Excellence at the Institute of Cancer Research (ICR), and Dr Fernando Carceller, Paediatric Neuro-Oncology Consultant at The Royal Marsden Hospital, tell us more.

Magazine article

How the latest treatments come about through clinical trials

New and innovative cancer treatments go through many steps to make their way from ‘bench to bedside’. Professor Pamela Kearns, Dr Sarah Al-Jilaihawi and Dr Jessica Douglas-Pugh from the University of Birmingham’s Cancer Research UK Clinical Trials Unit (CRCTU) explain more about this process.

Magazine article

The GRANS trial: Pioneering a novel treatment

Prof Robert Wynn, Consultant Paediatric Haematologist and Director of Bone Marrow Transplant at Royal Manchester Children’s Hospital, leads the GRANS clinical trial. He tells us how this innovative treatment is showing promising results for children with hard-to-treat leukaemia.

Magazine article

Molecular radiotherapy for children’s cancers

Molecular radiotherapy (MRT) is an evolving form of children’s cancer treatment. Dr Mark Gaze, Caroline Elmagrahi and Georgia Azzopardi, of University College London Hospitals NHS Foundation Trust, tell us more about what it is and what work is being done to develop its usage.

Magazine article

Taking back control

Emily Piszton was diagnosed with a type of brain tumour called craniopharyngioma in 2022, aged 11. Now 12, Emily explains how her tumour and its treatment caused her to gain weight, and what she did in response to this.